ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

Publisher, Law Firm Settle Suit Over Newsletter Photocopy

November 15, 1991

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.

July 28, 2000